Monitor upcoming quarterly filings (13F or earnings) to confirm these positions were held or increased. The cluster likely reflects passive rebalancing, but unanimous accumulation in a high-consensus biopharma stock could signal gradual institutional adoption ahead of catalysts.
Executive Summary
Six institutional investors accumulated AVBP shares in Q3 2024 with zero sellers, adding a net $4.4M to aggregate holdings (total $6.4M). The cluster is dominated by passive/index fund managers, reducing conviction, but the unanimous buying direction and strong past analyst consensus (95% bullish) suggest continued positive sentiment.
Key Financial Metrics
Institutional Positions
Net institutional flow: $4.4M
▲ Buyers (6)
| Institution | Action | Change | Position Value | Value Δ |
|---|---|---|---|---|
| Schwab | DOUBLED | +153.8% | $4.8M | $3.3M |
| Metlife Investment Management | DOUBLED | +168.9% | $384.0K | $271.0K |
| Rhumbline Advisers | DOUBLED | +164.6% | $790.0K | $554.0K |
| Mirae Asset Global Etfs Holdin | DOUBLED | +223.4% | $371.0K | $280.0K |
| Legal & General Group | DOUBLED | +198.1% | $67.0K | $49.0K |
Key Facts
- 6 institutions accumulated AVBP shares in Q3 2024, 0 sellers
- Net institutional buying of $4.4M (total holdings $6.4M)
- Schwab doubled its position to $4.8M, the largest buyer
- All buyers are passive/index funds or asset managers — no activist or high-alpha hedge funds involved
- AVBP has 95% analyst buy ratings (18 of 19 analysts bullish)
Financial Impact
6 institutions accumulated approximately $4.4M net new position value, with total Q3 2024 ending holdings of $6.4M. Schwab alone contributed $3.3M of that increase.
Risk Factors
- 13F data has a 45-day lag — positions may have been sold or reduced since Q3 end
- Cluster is dominated by passive/index funds, reducing the signal's active conviction
- Small absolute dollar amounts ($6.4M total) limit price impact relative to the float
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 institutional 13F filing from SEC EDGAR.
| Document | Accession Number |
|---|---|
| INST-CLUSTER Data (Synthetic) | inst-cluster-AVBP-2024-Q3 |
Filters
| Type | Now | ||||
|---|---|---|---|---|---|
Oct 26, 2026 today | 8-K | $23.64 | awaiting T+5 | — | — |
Oct 25, 2026 1d ago | Press Release | $21.00 | awaiting T+5 | — | — |
Oct 23, 2026 2d ago | Press Release | $21.00 | awaiting T+5 | — | — |
Oct 19, 2026 7d ago | 8-K | $17.94 | awaiting T+5 | — | — |
Oct 13, 2026 12d ago | SC 13G | $16.20 $19.12 | ▲ +18.02% | ▲ +17.57% | — |
Oct 13, 2026 13d ago | 8-K | $16.09 $18.85 | ▲ +17.15% | ▲ +18.31% | — |
Oct 8, 2026 17d ago | SC 13D/A | $16.73 $16.66 | ▲ +0.42% | ▼ −1.55% | — |
Oct 6, 2026 20d ago | 8-K | $15.09 $16.09 | ▼ −6.63% | ▼ −6.77% | — |
Aug 12, 2026 10w ago | Press Release | $30.00 $29.18 | ▲ +2.73% | ▲ +0.77% | — |
Jun 11, 2026 19w ago | Institutional Cluster | $30.54 $31.74 | ▲ +3.93% | ▲ +3.26% | — |
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers